Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EHA 2019 /
Inhibition of NADK strongly inhibits T-ALL cells from growing

13th - 16th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.06.19
Views: 522

Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK

Dr Etienne De Braekeleer presents results at the 2019 European Hematology Association (EHA) Annual Meeting from a study looking at the mutations in NOTCH1 that drive T-ALL cells to multiply rapidly.

A CRISPR-Cas9-based method was used to screen the human genome and highlight potential targetable genes.

Inhibiting one of these genes, NADK, was shown to greatly inhibit T-ALL cells from growing.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation